跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lupilan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lupilan
Approved
STANDARD
Lupilan
Jubilant Generics Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
73e4b7a5c73cff74
Company
Jubilant Generics Limited
Type
Standard
Approval Details
Approval Id
73e4b7a5c73cff74
Drug Approval Philippines Name
Lupilan
Product Name
Lupilan
Registration Number
DRP-5586
Brand Name
Lupilan
Generic Name
Olanzapine
Dosage Form
Orodispersible Tablet
Dosage Strength
10 mg
Manufacturer
Jubilant Generics Limited
Importer
MedEthix, Inc.
Distributor
Multicare Pharmaceutical Phils.
Company Detail Path
/organization/jubilant-generics-limited
Issuance Date
24 January 2022
Expiry Date
28 March 2027
Pharmacologic Category
Antipsychotics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
73e4b7a5c73cff74
Type
Standard
Back to Philippines FDA Approvals